JP2010526142A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526142A5
JP2010526142A5 JP2010507416A JP2010507416A JP2010526142A5 JP 2010526142 A5 JP2010526142 A5 JP 2010526142A5 JP 2010507416 A JP2010507416 A JP 2010507416A JP 2010507416 A JP2010507416 A JP 2010507416A JP 2010526142 A5 JP2010526142 A5 JP 2010526142A5
Authority
JP
Japan
Prior art keywords
methylpyrrolidine
tartrate
phenyl
optionally
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010507416A
Other languages
English (en)
Japanese (ja)
Other versions
JP5698887B2 (ja
JP2010526142A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/005702 external-priority patent/WO2008137087A1/en
Publication of JP2010526142A publication Critical patent/JP2010526142A/ja
Publication of JP2010526142A5 publication Critical patent/JP2010526142A5/ja
Application granted granted Critical
Publication of JP5698887B2 publication Critical patent/JP5698887B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010507416A 2007-05-03 2008-05-02 (r)−2−メチルピロリジンおよび(s)−2−メチルピロリジンならびにその酒石酸塩を調製するための方法 Expired - Fee Related JP5698887B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92735607P 2007-05-03 2007-05-03
US60/927,356 2007-05-03
PCT/US2008/005702 WO2008137087A1 (en) 2007-05-03 2008-05-02 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof

Publications (3)

Publication Number Publication Date
JP2010526142A JP2010526142A (ja) 2010-07-29
JP2010526142A5 true JP2010526142A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2011-06-23
JP5698887B2 JP5698887B2 (ja) 2015-04-08

Family

ID=39688886

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010507416A Expired - Fee Related JP5698887B2 (ja) 2007-05-03 2008-05-02 (r)−2−メチルピロリジンおよび(s)−2−メチルピロリジンならびにその酒石酸塩を調製するための方法

Country Status (14)

Country Link
EP (1) EP2152669A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP5698887B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR20100017565A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN101679237A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2008248168B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BRPI0810330A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2686033A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EA (1) EA019031B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL201627A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX2009011787A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ580948A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (1) UA99913C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2008137087A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA200907643B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA017004B1 (ru) 2006-07-25 2012-09-28 Сефалон, Инк. Пиридизиноновые производные
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof
EP2752406A1 (en) * 2008-01-30 2014-07-09 Cephalon, Inc. Substituted pyridazine derivatives which have histamine H3 antagonist activity
ES2707123T3 (es) * 2014-12-23 2019-04-02 Cephalon Inc Métodos para la preparación de derivados 2, 4-diaminopirimidin bicíclicos fusionados
TWI803692B (zh) * 2018-09-07 2023-06-01 法商賽諾菲公司 用於製備6-(2,4-二氯苯基)-5-[4-[(3s)-1-(3-氟丙基)吡咯啶-3-基]氧基苯基]-8,9-二氫-7h-苯并[7]輪烯-2-甲酸甲酯之方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329974A1 (de) 1983-08-19 1985-02-28 Bayer Ag, 5090 Leverkusen Herstellung von hydrierten nitrilkautschuken
DE3433392A1 (de) 1984-09-12 1986-03-20 Bayer Ag, 5090 Leverkusen Hydrierung nitrilgruppenhaltiger ungesaettigter polymerer
FR2714849B1 (fr) 1994-01-13 1996-04-05 Inst Francais Du Petrole Procédé de préparation d'un catalyseur d'hydrogénation soluble en phase liquide organique.
DE4403479A1 (de) 1994-02-04 1995-08-10 Basf Ag Verfahren zur Herstellung von Hydroxylammoniumsalzen
WO2004024707A2 (en) * 2002-09-16 2004-03-25 Abbott Laboratories Process for preparing amine type substituted benzofurans
US7153889B2 (en) 2002-11-12 2006-12-26 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
WO2005085307A1 (ja) 2004-03-08 2005-09-15 Japan Science And Technology Agency 高分子担持金属クラスター組成物
US7145005B2 (en) 2004-05-12 2006-12-05 Abbott Laboratories 2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation
CN1960727B (zh) 2004-06-02 2011-02-16 霍夫曼-拉罗奇有限公司 用作组胺-3受体的配体的萘衍生物
EP1820797A4 (en) 2004-12-01 2009-10-28 Banyu Pharma Co Ltd SUBSTITUTED PYRIDONE DERIVATIVE
CA2592353A1 (en) 2004-12-17 2006-06-22 Janssen Pharmaceutica, N.V. Tetrahydroisoquinoline compounds for treatment of cns disorders
JP2008526895A (ja) 2005-01-21 2008-07-24 シェーリング コーポレイション ヒスタミンh3アンタゴニストとして有用なイミダゾールおよびベンゾイミダゾール誘導体
US7790720B2 (en) 2005-03-31 2010-09-07 Ucb Pharma, S.A. Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
GB0514812D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
EP1943217A1 (en) 2005-10-27 2008-07-16 UCB Pharma, S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
EP1988777B1 (en) 2006-02-09 2011-09-21 Athersys, Inc. Pyrazoles for the treatment of obesity and other cns disorders
WO2007099423A1 (en) 2006-03-02 2007-09-07 Pfizer Products Inc. 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
CA2643055A1 (en) 2006-03-13 2007-09-20 Pfizer Products Inc. Tetralines antagonists of the h-3 receptor
EP2035372A1 (en) 2006-06-29 2009-03-18 Arena Pharmaceuticals, Inc. Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
EA017004B1 (ru) 2006-07-25 2012-09-28 Сефалон, Инк. Пиридизиноновые производные

Similar Documents

Publication Publication Date Title
JP7413363B2 (ja) メチル6-(2,4-ジクロロフェニル)-5-[4-[(3s)-1-(3-フルオロプロピル)ピロリジン-3-イル]オキシフェニル]-8,9-ジヒドロ-7h-ベンゾ[7]アヌレン-2-カルボキシレートの調製方法
JP2786480B2 (ja) 1―インドリルアルキル―4―(置換ピリジニル)ピペラジン
KR20200131241A (ko) 2종의 4-{[(2s)-2-{4-[5-클로로-2-(1h-1,2,3-트리아졸-1-일)페닐]-5-메톡시-2-옥소피리딘-1(2h)-일}부타노일]아미노}-2-플루오로벤즈아미드 유도체의 제조 방법
JP3085708B2 (ja) ピペラジン誘導体
ES2561834T3 (es) Naftiridonas y quinolonas 7-amino alquilidenil-heterocíclicas
TW201215601A (en) Method for producing 1-triazole-2-butanol derivative
CN101993405B (zh) 吲哚啉衍生物、及其制备方法和用途
JP2011042671A (ja) ピリジルテトラヒドロピリジン類及びピリジルピペリジン類とそれらの製造方法
HUT65837A (en) Process for producing phenoxy- and phenoxyalkyl-piperidines and pharmaceutical preparations containing them
RU2480461C2 (ru) Способ получения иматиниба и его промежуточных соединений
JP2010526142A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
US8716481B2 (en) Process for the preparation of 6-substituted-1-(2H)-isoquinolinones
JP5698887B2 (ja) (r)−2−メチルピロリジンおよび(s)−2−メチルピロリジンならびにその酒石酸塩を調製するための方法
JP6851149B2 (ja) ピペリジン化合物の製造方法
JP2002535365A (ja) 抗うつ性複素環化合物
ZA200308634B (en) 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders.
KR20150046456A (ko) 신규한 항진균성 옥소다이하이드로피리딘카보하이드라자이드 유도체
JP7252978B2 (ja) 2-(1-(tert-ブトキシカルボニル)ピペリジン-4-イル)安息香酸を調製するためのプロセス
SU680648A3 (ru) Способ получени производных пиперидина или их кислотноаддитивных солей
WO1984001945A1 (fr) Derives de phenoxyaminopropanol
WO2006118257A1 (ja) インダゾール-3-イルメチルホスホニウム塩の製造法
SU587861A3 (ru) Способ получени производных -диоксан-5-метиламина
JP2840855B2 (ja) ジヒドロピリジン誘導体の製造方法
ES2310152B2 (es) Procedimiento para la preparacion de 4-aril- 1,2,5,6-tetrahidropiridinas.
JPS6366312B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)